Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds.
Behav Brain Res
; 173(1): 39-46, 2006 Oct 02.
Article
em En
| MEDLINE
| ID: mdl-16857277
ABSTRACT
Animal models of drug discrimination have been used to examine the subjective effects of addictive substances. The cAMP system is a crucial downstream signaling pathway implicated in the long-lasting neuroadaptations induced by addictive drugs. We examined effects of rolipram, nefiracetam, and dopamine D2-like receptor antagonists, all of which have been reported to modulate cAMP level in vivo, on the discriminative-stimulus effects of methamphetamine (METH) and morphine in rats. All these compounds inhibited the discriminative-stimulus effects of METH, while only rolipram and nefiracetam attenuated the discriminative-stimulus effects of morphine. In addition, neither nifedipine nor neomycin, two voltage-sensitive calcium channel blockers, was found to modulate the effect of nefiracetam on METH-associated discriminative stimuli, suggesting that the inhibitory effect of nefiracetam may not involve the activation of calcium channels. These findings suggest that the cAMP signaling cascade may play a key role in the discriminative-stimulus effects of METH and morphine and may be a potential target for the development of therapeutics to counter drugs of abuse.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Transdução de Sinais
/
AMP Cíclico
/
Aprendizagem por Discriminação
/
Estimulantes do Sistema Nervoso Central
/
Metanfetamina
/
Morfina
/
Entorpecentes
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Article